Dr. Lal Pathlabs
LALPATHLAB · Healthcare > Hospital & Healthcare Services · Chairman: Arvind Lal · MD: Om Prakash Manchanda · Listing date: Dec. 23, 2015 · Employees: 3996 · Gurgaon · http://www.lalpathlabs.com

Stock Price vs Company Growth
1d
0.3%
1w
1.4%
1m
8.2%
3m
16.3%
6m
21.7%
1y
6.7%
5y
10.2%
all
14.0%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec14Dec16Dec18Dec20Dec22Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

2,589 0.3%
2,548
3,200
Company Overview

Sales
2,404 Cr
Growth: 9.6%
Profit after Tax
417 Cr
Growth: 3.8%
Mid Cap
21,644 Cr
P/E: 51.8x
Industry P/E: 50.8x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 2,404
Growth 9.6%
EBITDA 27.9%
P/S 9.0x
Dividend 1.0%
P/E 51.8x
Book Value ₹ 261
PEG Ratio 5.4x
ROE 20.7%
P/B 9.9x
Shareholding Pattern

Institutions
Invesco Oppenheimer International Growth Fund
2.8 %
Uti Flexi Cap Fund
2.03 %
Al Mehwar Commercial Investments Llc - (Wanda)
1.0 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Dec21Sep22Sep24
Promoters
Arvind Lal
31.69 %
Vandana Lal
19.3 %
Archana Lal Erdmann
2.21 %
Anjaneya Lal
2.03 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Dec21Sep22Sep24
Others
Westbridge Crossover Fund, Llc
3.58 %
Om Prakash Manchanda
1.77 %
Llp
0.07 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21Dec21Sep22Sep24
Increase    Decrease    No change
Company Profile Detailed

The company is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
Investors (110)
Followers (30)